Corporate Integrity Agreement (CIA)
Definition
A Corporate Integrity Agreement (CIA) is a formal, legally binding agreement negotiated between a healthcare organization and the HHS OIG, typically following a settlement of allegations of fraud, waste, or abuse in federal health care programs. CIAs impose specific compliance obligations on the organization for a defined period, usually five years.
In the 340B context, a CIA may be relevant when a covered entity’s compliance failures rise to the level of fraud or abuse allegations. CIAs typically require the organization to implement enhanced compliance programs, hire independent review organizations, submit regular compliance reports, and accept ongoing OIG monitoring.
While most 340B compliance issues are addressed through HRSA’s CAP process rather than OIG enforcement, covered entities should understand that serious or repeated violations can escalate to OIG involvement and potentially a CIA.
Frequently Asked Questions
Why Corporate Integrity Agreement (CIA) Matters
A CIA represents a significant escalation of compliance obligations and oversight. The compliance infrastructure and monitoring requirements imposed by a CIA are far more burdensome than proactive compliance investment. Understanding this risk reinforces the value of maintaining a strong compliance program.
How Virtue 340B Uses It
Virtue 340B helps covered entities build compliance programs strong enough to prevent the escalation of issues to OIG involvement. Our audit and monitoring services are designed to identify and remediate problems at the HRSA level, before they become federal enforcement matters.